Recall Z-0554-2019— Pfizer Inc.

Class II · Terminated

Class II FDA medical device recall by Pfizer Inc., initiated 2018-10-02, terminated 2023-08-28. FDA's recall record names no specific 510(k) clearance for this event. Product: Thermacare Muscle Pain Therapy HeatWraps: a) UPC 0573301314 b) UPC 0573301303 Product Usage: Provides heat therapy for temporary relief of minor muscular and joint aches and pains associated with overexertion, sprains, and arthritis.. Reason: The firm received complaints of the wrap coming apart and leaking granular material.

Recalling firm
Pfizer Inc.
Classification
Class II
Status
Terminated
Initiated
2018-10-02
Terminated
2023-08-28
Firm location
New York, NY, United States

Product description

Thermacare Muscle Pain Therapy HeatWraps: a) UPC 0573301314 b) UPC 0573301303 Product Usage: Provides heat therapy for temporary relief of minor muscular and joint aches and pains associated with overexertion, sprains, and arthritis.

Reason for recall

The firm received complaints of the wrap coming apart and leaking granular material

Data sourced from openFDA. This site is unofficial and independent of the FDA.